生脉注射液对慢性阻塞性肺病患者呼吸功能的疗效观察

作者	单位
方宗君	上海市宝山区吴淞中心医院呼吸内科!上海200940
蒋浩明	上海市宝山区吴淞中心医院呼吸内科!上海200940
王丽华	上海市宝山区吴淞中心医院呼吸内科!上海200940

摘要点击次数: 1458

全文下载次数: 1127

中文摘要:

目的 :探讨生脉注射液对慢性阻塞性肺病患者呼吸功能的影响。方法 :治疗组 (2 0例)在西医常规治疗的基础上 ,静脉滴注生脉注射液共 1 4天 ,测定治疗前后肺活量、用力肺活量(FVC)、第 1秒用力呼气容积(FEV1 )、FEV1 占FVC比值 (FEV1 /FVC)、最大通气量、最大吸气压、负荷呼吸时间、动脉血气分析和Borg呼吸困难评分 ,并作治疗前后自身对照和与西医常规治疗对照组比较分析。结果 :除FVC和FEV1 /FVC比值外 ,治疗组在治疗后各项指标均优于对照组或本组治疗前水平 (P <0 0 5)。结论 :生脉注射液可改善慢性阻塞性肺病患者呼吸功能

英文摘要:

objective To explore the therapeutic effect of Shengmai injection (SMI) on respiratory function in chronic obstructive pulmonary disease (COPD). Methods: Twenty patients with COPD were continuously treated with SMI by intravenous drip in 14 days and examined the lung vital capacity (VC), forced vital capacity (FVC), forced vital capacity of the first second (FEV 1), FEV 1/FVC, maximum voluntory ventilation (MVV), maximum inspiratory pressure (MIP), load respiratory time (LT), 6 minute walk distance (6 MWD), arterial blood gas analysis, and Borg dyspnea scale before and after treatment respectively and compared with itself or control group. Results: After treatment all parameters of the treatment group were better than those of control group or itself before treatment except for FVC and FEV 1/FVC. There were significant difference (P<0 05). Conclusion: SMI can improve respiratory function in COPD. So it is an effective rehabilitative measure in treating COPD.

关闭